{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:49:54Z","timestamp":1790866194194,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.nucmedbio.2003.08.007","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T11:42:33Z","timestamp":1078573353000},"page":"199-203","source":"Crossref","is-referenced-by-count":40,"title":["Preparation and biodistribution of technetium-99m-labeled 1-(2-nitroimidazole-1-yl)-propanhydroxyiminoamide (N2IPA) as a tumor hypoxia marker"],"prefix":"10.1016","volume":"31","author":[{"given":"Taiwei","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB1","first-page":"1023","article-title":"In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia","volume":"37","author":"Ballinger","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB2","first-page":"145","article-title":"Preparation and biodistribution of 99Tcm-AIPO","volume":"23","author":"Chu","year":"2001","journal-title":"J Nucl Radiochem"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB3","first-page":"335","article-title":"Tumor hypoxia","volume":"25","author":"Cook","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/cr60216a003","article-title":"The chemistry of amidoximes and related compounds","volume":"62","author":"Eloy","year":"1962","journal-title":"Chem Rev"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB5","first-page":"68","article-title":"Synthesis and characterization of congeners of misonidazole for imaging hypoxia","volume":"28","author":"Grunbaum","year":"1987","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB6","series-title":"Org Syntheses, Coll. Vol. 2","first-page":"67","article-title":"Benzohydroxamic acid","author":"Hauser","year":"1943"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB7","first-page":"1764","article-title":"Radioiodinated 1-(5-iodo-5-deoxy-\u00e1-darabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside:IAZA)","volume":"32","author":"Mannan","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006231-199206000-00045","article-title":"Hydroxamamide as a chelating moiety for the preparation of 99mTc radiopharmaceuticals(I)","volume":"13","author":"Nakayama","year":"1992","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0969-8043(94)90254-2","article-title":"Hydroxamamide as a chelating moiety for the preparation of 99mTc radiopharmaceuticals-II. The 99mTc complexes of hydroxamamide derivatives","volume":"45","author":"Nakayama","year":"1994","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0969-8043(96)00334-X","article-title":"Hydroxamamide as a chelating moiety for the preparation of 99mTc radiopharmaceuticals-III. Characterization of various Tc-99m-hydroxamamides","volume":"48","author":"Nakayama","year":"1997","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01081524","article-title":"Nitroimidazoles and imaging hypoxia","volume":"22","author":"Nunn","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB12","first-page":"531","article-title":"Michael addition of imidazoles with acrylonitrile and acrylic acid","volume":"13","author":"Rahman","year":"1975","journal-title":"Indian J Chem"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB13","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/0040-4020(95)00042-7","article-title":"Synthesis of nitroimidazole substituted 3,3,9,9-tetramethyl-4,8-diazaundecane-2,10-dione dioximes (propylene amine oximes, PnAOs)","volume":"51","author":"Ramalingam","year":"1995","journal-title":"Tetrahedron"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jhet.5570160509","article-title":"Hydroxymethlation and cyanoethylation of nitroimidazoles(1)","volume":"16","author":"Sehgal","year":"1979","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.nucmedbio.2003.08.007_BIB15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.194.3.7862981","article-title":"Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia","volume":"194","author":"Yang","year":"1995","journal-title":"Radiology"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805103001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805103001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T19:54:21Z","timestamp":1550174061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805103001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0969805103001537"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2003.08.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}